You cannot purchase it over the counter
Opportunities for Retail With the shift in consumer behaviors due to GLP-1 drugs, there has been a significant impact on purchasing patterns, thus influencing retailers
Aims to prevent breathing interruptions Health Canada's approval follows Phase 3 clinical trials with patients who had both obesity and sleep apnea
It decreases glucagon secretion, delays stomach emptying, and increases the release of insulin, all of which help control blood sugar levels and promote weight loss
55 A systematic review and meta-analysis of 7 RCTs was done to see the efficacy and safety of orforglipron and danuglipron in the treatment of T2DM and obesity
Oral therapies and off patent semaglutide will affect pricing and access, competition intensifies in an increasingly segmented market, and innovation shifts the focus beyond weight loss alone towards comorbidity benefit, long-term maintenance and muscle preservation